User:cecilytbkj857280

Bavituximab, referred to as TRWH-783, represents a unique treatment strategy targeting phosphatidylserine (PS). PS is typically an internal lipid present on cell membranes; however, it's often

https://www.targetmol.com/compound/bavituximab